- R D-Driven and AI-Powered Biopharma Company | Sanofi
Sanofi is a research development-driven, AI-powered healthcare biopharma company committed to improving lives through innovative medicines vaccines
- Sanofi - Wikipedia
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications
- Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USA
Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments
- Working at Sanofi
Discover new opportunities to grow, find your perfect role This is an incredibly exciting time to be in biopharma At Sanofi, you’ll join a team that shares a purpose, embraces new ideas, and seizes opportunities to improve people’s lives
- Sanofi - LinkedIn
Sanofi | 4,385,117 followers on LinkedIn We are Sanofi, an innovative global healthcare company We chase the miracles of science to improve people’s lives Our team, across some 100 countries
- Sanofi to invest at least $20 billion in the US through 2030, growing . . .
About Sanofi We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible
- Our Company - Sanofi U. S.
Learn about Sanofi, a leading global pharmaceutical company in the US, advancing specialty care, vaccines, and consumer healthcare
- Frances Sanofi to invest at least $20 billion in US through 2030
May 14 (Reuters) - Sanofi (SASY PA), opens new tab plans to invest at least $20 billion in the United States through 2030 to boost manufacturing and research, joining other drugmakers in expanding
|